Intramyocardial injection of skeletal myoblasts: long-term follow-up with pressure-volume loops

Nature Clinical Practice. Cardiovascular Medicine
Paul SteendijkPatrick W Serruys

Abstract

The human heart has a limited capacity for self-repair because, unlike most other cells, cardiomyocytes do not regenerate. Therefore, if a substantial number of myocytes is lost after a myocardial infarction, the performance of the heart may become severely limited, leading to a condition of heart failure. Recently, cell transplantation has emerged as a potential therapy for patients with end-stage heart failure. Of the various cell types being investigated for this purpose, skeletal myoblasts are an attractive option, because they are readily available from muscle biopsies and, if autologous cells are used, immunosuppression is not required and ethical issues are avoided. Several studies have shown that the cells can survive and differentiate after transplantation, and promising clinical results have been reported. However, effects of this therapy on left ventricular function remain largely unknown. In the present study, we investigated the long-term hemodynamic effects of intramyocardial injection of autologous skeletal myoblasts in patients with ischemic heart failure. Our findings indicate hemodynamic improvement after follow-up for up to 1 year, which is especially promising in view of the expected decline in left ventricu...Continue Reading

References

Sep 1, 1993·The Journal of Clinical Investigation·G Y KohL J Field
Jul 17, 2001·American Journal of Physiology. Heart and Circulatory Physiology·P SteendijkJ Baan
Jan 5, 2002·The New England Journal of Medicine·Federico QuainiPiero Anversa
Jul 31, 2002·Circulation·Scott W BallingerMarschall S Runge
Jul 31, 2002·Congestive Heart Failure·Jochen Müller-EhmsenRobert A Kloner
Apr 8, 2003·Journal of the American College of Cardiology·Philippe MenaschéDenis Duboc
May 22, 2003·Cardiovascular Research·Joshua D DowellLoren J Field
May 22, 2003·Cardiovascular Research·Philippe Menasché
Jun 14, 2003·Proceedings of the National Academy of Sciences of the United States of America·Bertrand LeobonSerge Charpak
Oct 22, 2003·Circulation·Kevin C Abbott, George L Bakris
Dec 19, 2003·Journal of the American College of Cardiology·Raj R MakkarPeng-Sheng Chen
Mar 17, 2004·Proceedings of the National Academy of Sciences of the United States of America·Bari MurtuzaMagdi H Yacoub
Apr 13, 2004·Current Opinion in Cardiology·Philippe Menasché
Jul 21, 2004·Journal of the American College of Cardiology·Onnik AgbulutPhilippe Menasché
Mar 1, 2005·Coronary Artery Disease·Philippe Menasché

❮ Previous
Next ❯

Citations

Jun 19, 2010·Journal of Cardiovascular Translational Research·Peter J PsaltisStephen G Worthley
May 21, 2010·Artificial Organs·Marie-Noëlle GiraudHendrik Tevaearai
Jan 7, 2010·The Journal of Clinical Investigation·Francesco Saverio TedescoGiulio Cossu
May 1, 2008·Future Cardiology·M Ian PhillipsKai Pinkernell
Jan 22, 2011·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·Henricus J DuckersPatrick W Serruys
Dec 26, 2006·Expert Review of Cardiovascular Therapy·Aravinda NanjundappaWayne E Cascio
May 31, 2008·Expert Review of Cardiovascular Therapy·Emil RuvinovSmadar Cohen
Aug 22, 2006·Expert Opinion on Biological Therapy·Harald C Ott, Doris A Taylor
Aug 31, 2014·Advanced Drug Delivery Reviews·Conn L HastingsGarry P Duffy
Jul 18, 2009·Biomaterials·Jennifer M SingelynKaren L Christman
Aug 30, 2008·Journal of the American College of Surgeons·Nathan M NovotnyDaniel R Meldrum
Aug 11, 2007·Critical Reviews in Oncology/hematology·Caroline AméenPeter Sartipy
Dec 3, 2014·The Journal of Thoracic and Cardiovascular Surgery·Philipp TreskesYeong-Hoon Choi
May 10, 2006·Journal of the American College of Cardiology·Patrick W Serruys
Nov 24, 2006·Cell Transplantation·Zhongmin LiuBing-guan Chen
Feb 8, 2007·Current Opinion in Cardiology·Rebecca AllanHaissam Haddad
Feb 16, 2011·Macromolecular Bioscience·Jennifer M Singelyn, Karen L Christman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.